This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (305)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Neurology  • Alzheimer Disease  • Women's Health  • Menopause  • Alert me on articles by topic  Social Bookmarking   What's this?

The Cache County Study

Peter P. Zandi, PhD; Michelle C. Carlson, PhD; Brenda L. Plassman, PhD; Kathleen A. Welsh-Bohmer, PhD; Lawrence S. Mayer, MD; David C. Steffens, MD; John C. S. Breitner, MD; for the Cache County Memory Study Investigators

JAMA. 2002;288:2123-2129.

Context  Previous studies have shown a sex-specific increased risk of Alzheimer disease (AD) in women older than 80 years. Basic neuroscience findings suggest that hormone replacement therapy (HRT) could reduce a woman's risk of AD. Epidemiologic findings on AD and HRT are mixed.

Objective  To examine the relationship between use of HRT and risk of AD among elderly women.

Design, Setting, and Participants  Prospective study of incident dementia among 1357 men (mean age, 73.2 years) and 1889 women (mean age, 74.5 years) residing in a single county in Utah. Participants were first assessed in 1995-1997, with follow-up conducted in 1998-2000. History of women's current and former use of HRT, as well as of calcium and multivitamin supplements, was ascertained at the initial contact.

Main Outcome Measure  Diagnosis of incident AD.

Results  Thirty-five men (2.6%) and 88 women (4.7%) developed AD between the initial interview and time of the follow-up (3 years). Incidence among women increased after age 80 years and exceeded the risk among men of similar age (adjusted hazard ratio [HR], 2.11; 95% confidence interval [CI], 1.22-3.86). Women who used HRT had a reduced risk of AD (26 cases among 1066 women) compared with non-HRT users (58 cases among 800 women) (adjusted HR, 0.59; 95% CI, 0.36-0.96). Risk varied with duration of HRT use, so that a woman's sex-specific increase in risk disappeared entirely with more than 10 years of treatment (7 cases among 427 women). Adjusted HRs were 0.41 (95% CI, 0.17-0.86) for HRT users compared with nonusers and 0.77 (95% CI, 0.31-1.67) compared with men. No similar effect was seen with calcium or multivitamin use. Almost all of the HRT-related reduction in incidence reflected former use of HRT (9 cases among 490 women; adjusted HR, 0.33 [95% CI, 0.15-0.65]). There was no effect with current HRT use (17 cases among 576 women; adjusted HR, 1.08 [95% CI, 0.59-1.91]) unless duration of treatment exceeded 10 years (6 cases among 344 women; adjusted HR, 0.55 [95% CI, 0.21-1.23]).

Conclusions  Prior HRT use is associated with reduced risk of AD, but there is no apparent benefit with current HRT use unless such use has exceeded 10 years.

Author Affiliations: Department of Mental Hygiene, School of Hygiene and Public Health, the Johns Hopkins University, Baltimore, Md (Drs Zandi, Carlson, Mayer, and Breitner); Department of Psychiatry and Behavioral Sciences (Drs Plassman, Welsh-Bohmer, and Steffens), and The Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC (Dr Welsh-Bohmer); Banner Health System, Phoenix, Ariz (Dr Mayer); and VA Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle (Dr Breitner).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Estrogen Replacement and Risk of Alzheimer Disease
Mark A. Smith, George Perry, Craig S. Atwood, and Richard L. Bowen
JAMA. 2003;289(9):1100.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Amnon Lahad and Lev Ishay
JAMA. 2003;289(9):1100-1101.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
J. Galen Buckwalter, Diana B. Petitti, and Valerie C. Crooks
JAMA. 2003;289(9):1101.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Lynn Rosenberg
JAMA. 2003;289(9):1101.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease—Reply
Susan M. Resnick and Victor W. Henderson
JAMA. 2003;289(9):1102.
EXTRACT | FULL TEXT  

Effects of Estrogen Plus Progestin on Risk of Dementia
John C. S. Breitner and Peter P. Zandi
JAMA. 2003;290(13):1706-1707.
EXTRACT | FULL TEXT  

Effects of Estrogen Plus Progestin on Risk of Dementia
Istvan Nyirjesy and Frank S. Billingsley
JAMA. 2003;290(13):1707.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
Susan M. Resnick and Victor W. Henderson
JAMA. 2002;288(17):2170-2172.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hormone therapy and cognitive function
Maki and Sundermann
Hum Reprod Update 2009;15:667-681.
ABSTRACT | FULL TEXT  

Ovariectomy and 17{beta}-Estradiol Replacement Do Not Alter {beta}-Amyloid Levels in Sheep Brain
Barron et al.
Endocrinology 2009;150:3228-3236.
ABSTRACT | FULL TEXT  

Gonadal Steroids Maintain 24 h Acetylcholine Release in the Hippocampus: Organizational and Activational Effects in Behaving Rats
Mitsushima et al.
J. Neurosci. 2009;29:3808-3815.
ABSTRACT | FULL TEXT  

A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor {beta}-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo
Zhao et al.
Endocrinology 2009;150:770-783.
ABSTRACT | FULL TEXT  

Steroidogenic Capacity of Residual Ovarian Tissue in 4-Vinylcyclohexene Diepoxide-Treated Mice
Rivera et al.
Biol. Reprod. 2009;80:328-336.
ABSTRACT | FULL TEXT  

The Potential for Estrogens in Preventing Alzheimer's Disease.
Simpkins et al.
Therapeutic Advances in Neurological Disorders 2009;2:31-49.
ABSTRACT  

Reassessing Benefits and Risks of Hormone Therapy
Gass et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:29-43.
ABSTRACT  

Approach to the Patient with Menopausal Symptoms
Martin and Manson
J. Clin. Endocrinol. Metab. 2008;93:4567-4575.
ABSTRACT | FULL TEXT  

Neuroprotective effects of the Alzheimer's disease-related gene seladin-1
Peri and Serio
J Mol Endocrinol 2008;41:251-261.
ABSTRACT | FULL TEXT  

Dementia Prevention: Methodological Explanations for Inconsistent Results
Coley et al.
Epidemiol Rev 2008;30:35-66.
ABSTRACT | FULL TEXT  

STATIN THERAPY IS ASSOCIATED WITH REDUCED NEUROPATHOLOGIC CHANGES OF ALZHEIMER DISEASE
Golomb et al.
Neurology 2008;70:2349-2330.
FULL TEXT  

Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
Carroll and Pike
Endocrinology 2008;149:2607-2611.
ABSTRACT | FULL TEXT  

Incidence of Dementia in Long-term Hormone Users
Petitti et al.
Am J Epidemiol 2008;167:692-700.
ABSTRACT | FULL TEXT  

Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Carroll et al.
J. Neurosci. 2007;27:13357-13365.
ABSTRACT | FULL TEXT  

Hormone therapy in menopausal women with cognitive complaints: A randomized, double-blind trial
Maki et al.
Neurology 2007;69:1322-1330.
ABSTRACT | FULL TEXT  

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause
Rocca et al.
Neurology 2007;69:1074-1083.
ABSTRACT | FULL TEXT  

Does NSAID use modify cognitive trajectories in the elderly?: The Cache County Study
Hayden et al.
Neurology 2007;69:275-282.
ABSTRACT | FULL TEXT  

Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Schumacher et al.
Endocr. Rev. 2007;28:387-439.
ABSTRACT | FULL TEXT  

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group
Neurology 2007;68:1800-1808.
ABSTRACT | FULL TEXT  

Estrogen, cognition and female ageing
Genazzani et al.
Hum Reprod Update 2007;13:175-187.
ABSTRACT | FULL TEXT  

Activation of estrogen receptor {alpha} increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo
Wang et al.
Proc. Natl. Acad. Sci. USA 2006;103:16983-16988.
ABSTRACT | FULL TEXT  

Dose and Temporal Pattern of Estrogen Exposure Determines Neuroprotective Outcome in Hippocampal Neurons: Therapeutic Implications
Chen et al.
Endocrinology 2006;147:5303-5313.
ABSTRACT | FULL TEXT  

Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
Morrison et al.
J. Neurosci. 2006;26:10332-10348.
FULL TEXT  

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Turgeon et al.
Endocr. Rev. 2006;27:575-605.
ABSTRACT | FULL TEXT  

Dementia--Epidemiological Considerations, Nomenclature, and a Tacit Consensus Definition
Breitner
J Geriatr Psychiatry Neurol 2006;19:129-136.
ABSTRACT  

Novel Mechanisms for Estrogen-Induced Neuroprotection.
Singh et al.
Exp. Biol. Med. 2006;231:514-521.
ABSTRACT | FULL TEXT  

Estrogen Alters Spine Number and Morphology in Prefrontal Cortex of Aged Female Rhesus Monkeys
Hao et al.
J. Neurosci. 2006;26:2571-2578.
ABSTRACT | FULL TEXT  

Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Rippon et al.
Neurology 2006;66:35-40.
ABSTRACT | FULL TEXT  

Role of Protein Phosphatases in Estrogen-Mediated Neuroprotection
Yi et al.
J. Neurosci. 2005;25:7191-7198.
ABSTRACT | FULL TEXT  

Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease
Green et al.
Endocrinology 2005;146:2774-2781.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy: from monkey glands to transdermal patches
Davis et al.
J Endocrinol 2005;185:207-222.
ABSTRACT | FULL TEXT  

Effect of Estrogen-Serotonin Interactions on Mood and Cognition
Amin et al.
Behav Cogn Neurosci Rev 2005;4:43-58.
ABSTRACT  

Navigating the Journey to Menses Cessation: A Study of Change in an Emancipatory Context
Matarese
J Holist Nurs 2005;23:34-50.
ABSTRACT  

Estrogen and Selective Estrogen Receptor Modulators Exert Neuroprotective Effects and Stimulate the Expression of Selective Alzheimer's Disease Indicator-1, a Recently Discovered Antiapoptotic Gene, in Human Neuroblast Long-Term Cell Cultures
Benvenuti et al.
J. Clin. Endocrinol. Metab. 2005;90:1775-1782.
ABSTRACT | FULL TEXT  

Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?: The Cache County Study
Zandi et al.
Arch Gen Psychiatry 2005;62:217-224.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age
Henderson et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:103-105.
ABSTRACT | FULL TEXT  

Both estrogen and raloxifene protect against {beta}-amyloid-induced neurotoxicity in estrogen receptor {alpha}-transfected PC12 cells by activation of telomerase activity via Akt cascade
Du et al.
J Endocrinol 2004;183:605-615.
ABSTRACT | FULL TEXT  

17{beta}-Estradiol Differentially Regulates Blood-Brain Barrier Permeability in Young and Aging Female Rats
Bake and Sohrabji
Endocrinology 2004;145:5471-5475.
ABSTRACT | FULL TEXT  

Hormone Therapy: Making Decisions in the Face of Uncertainty
Peterson et al.
Arch Intern Med 2004;164:2308-2312.
FULL TEXT  

Estrogen Modulates Microglial Inflammatory Mediator Production via Interactions with Estrogen Receptor {beta}
Baker et al.
Endocrinology 2004;145:5021-5032.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women
Kang et al.
Neurology 2004;63:101-107.
ABSTRACT | FULL TEXT  

Estrogen Facilitates Neurite Extension via Apolipoprotein E in Cultured Adult Mouse Cortical Neurons
Nathan et al.
Endocrinology 2004;145:3065-3073.
ABSTRACT | FULL TEXT  

The Follicle-Deplete Mouse Ovary Produces Androgen
Mayer et al.
Biol. Reprod. 2004;71:130-138.
ABSTRACT | FULL TEXT  

Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study
Shumaker et al.
JAMA 2004;291:2947-2958.
ABSTRACT | FULL TEXT  

Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women's Health Initiative Memory Study
Espeland et al.
JAMA 2004;291:2959-2968.
ABSTRACT | FULL TEXT  

Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study
Schneider
JAMA 2004;291:3005-3007.
FULL TEXT  

Delirium and Dementia
Ajilore and Kumar
Focus 2004;2:210-220.
ABSTRACT | FULL TEXT  

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study
Zandi et al.
Arch Neurol 2004;61:82-88.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Therapy and Its Association With Cognitive Impairment
Mitchell et al.
Arch Intern Med 2003;163:2485-2490.
ABSTRACT | FULL TEXT  

Oestrogen plus progestin doubles the risk of dementia in post-menopausal women
Sherwin and McGill
Evid. Based Ment. Health 2003;6:111-111.
FULL TEXT  

Detangling Alzheimer's Disease
Helmuth
Sci Aging Knowl Environ 2003;2003:oa2-2.
ABSTRACT | FULL TEXT  

Effects of Estrogen Plus Progestin on Risk of Dementia
Breitner and Zandi
JAMA 2003;290:1706-1707.
FULL TEXT  

Effects of Estrogen Plus Progestin on Risk of Dementia
Nyirjesy and Billingsley
JAMA 2003;290:1707-1707.
FULL TEXT  

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling
Nilsen and Brinton
Proc. Natl. Acad. Sci. USA 2003;100:10506-10511.
ABSTRACT | FULL TEXT  

Managing Alzheimer Dementia Tomorrow
Rosenthal and Khotianov
J Am Board Fam Med 2003;16:423-434.
ABSTRACT | FULL TEXT  

Estrogen receptor-{alpha} mediates the brain antiinflammatory activity of estradiol
Vegeto et al.
Proc. Natl. Acad. Sci. USA 2003;100:9614-9619.
ABSTRACT | FULL TEXT  

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
Shumaker et al.
JAMA 2003;289:2651-2662.
ABSTRACT | FULL TEXT  

Hormone Therapy and the Brain: Deja Vu All Over Again?
Yaffe
JAMA 2003;289:2717-2719.
FULL TEXT  

Risks and benefits of hormone replacement therapy: The evidence speaks
Humphries and Gill
CMAJ 2003;168:1001-1010.
ABSTRACT | FULL TEXT  

Estrogen and Cognitive Functioning in Women
Sherwin
Endocr. Rev. 2003;24:133-151.
ABSTRACT | FULL TEXT  

Estrogen and Cognition: The Story So Far
Asthana
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M322-323.
FULL TEXT  

Management of Alzheimer's Disease
Grossberg and Desai
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M331-353.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Smith et al.
JAMA 2003;289:1100-1100.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Buckwalter et al.
JAMA 2003;289:1101-1101.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease--Reply
Resnick and Henderson
JAMA 2003;289:1102-1102.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Lahad and Ishay
JAMA 2003;289:1100-1101.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Rosenberg
JAMA 2003;289:1101-1101.
FULL TEXT  

Selective Estrogen-Receptor Modulators -- Mechanisms of Action and Application to Clinical Practice
Riggs and Hartmann
NEJM 2003;348:618-629.
FULL TEXT  

HRT and Alzheimer's Disease -- Some Encouragement, More Uncertainty
JWatch Psychiatry 2003;2003:11-11.
FULL TEXT  

Hormone Therapy Associated with Lower Incidence of Alzheimer's Disease
JWatch Women's Health 2002;2002:4-4.
FULL TEXT  

HRT and Alzheimer's Disease -- Some Encouragement, More Uncertainty
JWatch General 2002;2002:3-3.
FULL TEXT  

Long term HRT may protect women from Alzheimer's disease
Gottlieb
BMJ 2002;325:1130-1130.
FULL TEXT  

Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
Resnick and Henderson
JAMA 2002;288:2170-2172.
FULL TEXT